ReviewThe journal of pathology. Clinical research2023

Tropomyosin receptor kinase B (TrkB) signalling: targeted therapy in neurogenic tumours.

Yuehua Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.